Outlook For These Biotechs Brightens As FDA Ushers In New Rules For Sector
investors.com/stock-lists/ibd-50/biotech-stocks-globus-medical-genetic-test-gmed-wgs/?src=A00220
Two health care stocks have earned their spot on the IBD 50 after a strong run in 2024. Globus Medical (GMED) and GeneDx (WGS) are also in buy zones as they continue to outperform.
Globus Medical makes products to treat certain spinal conditions. Shares have broken out from a flat base…
This story appeared on investors.com, 2025-01-10 17:29:22.